The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Natural Killer (NK) Cell Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The global Natural Killer (NK) Cell Therapeutics market size is expected to reach US$ 324.8 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Natural Killer (NK) Cell Therapeutics in various end use industries. The expanding demands from the Cancer, Cardiovascular Diseases and Others,, are propelling Natural Killer (NK) Cell Therapeutics market. Mogamulizumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lorvotuzumab Mertansine segment is estimated at % CAGR for the next seven-year period.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Natural Killer (NK) Cell Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Natural Killer (NK) Cell Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Natural Killer (NK) Cell Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Natural Killer (NK) Cell Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Natural Killer (NK) Cell Therapeutics covered in this report include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc.
The global Natural Killer (NK) Cell Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Global Natural Killer (NK) Cell Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Natural Killer (NK) Cell Therapeutics market, Segment by Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
Global Natural Killer (NK) Cell Therapeutics market, by Application
Cancer
Cardiovascular Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Natural Killer (NK) Cell Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The global Natural Killer (NK) Cell Therapeutics market size is expected to reach US$ 324.8 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Natural Killer (NK) Cell Therapeutics in various end use industries. The expanding demands from the Cancer, Cardiovascular Diseases and Others,, are propelling Natural Killer (NK) Cell Therapeutics market. Mogamulizumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lorvotuzumab Mertansine segment is estimated at % CAGR for the next seven-year period.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Natural Killer (NK) Cell Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Natural Killer (NK) Cell Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Natural Killer (NK) Cell Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Natural Killer (NK) Cell Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Natural Killer (NK) Cell Therapeutics covered in this report include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc.
The global Natural Killer (NK) Cell Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Global Natural Killer (NK) Cell Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Natural Killer (NK) Cell Therapeutics market, Segment by Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
Global Natural Killer (NK) Cell Therapeutics market, by Application
Cancer
Cardiovascular Diseases
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Natural Killer (NK) Cell Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Natural Killer (NK) Cell Therapeutics
1.1 Natural Killer (NK) Cell Therapeutics Market Overview
1.1.1 Natural Killer (NK) Cell Therapeutics Product Scope
1.1.2 Natural Killer (NK) Cell Therapeutics Market Status and Outlook
1.2 Global Natural Killer (NK) Cell Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2029)
1.4 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Natural Killer (NK) Cell Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.2 Europe Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.4 Latin America Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size (2018-2029)
2 Natural Killer (NK) Cell Therapeutics Market by Type
2.1 Introduction
2.1.1 Mogamulizumab
2.1.2 Lorvotuzumab Mertansine
2.1.3 Others
2.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Type (2018-2029)
3 Natural Killer (NK) Cell Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Cardiovascular Diseases
3.1.3 Others
3.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Breakdown by Application (2018-2029)
4 Natural Killer (NK) Cell Therapeutics Competition Analysis by Players
4.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2022)
4.3 Date of Key Players Enter into Natural Killer (NK) Cell Therapeutics Market
4.4 Global Top Players Natural Killer (NK) Cell Therapeutics Headquarters and Area Served
4.5 Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Natural Killer (NK) Cell Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Chipscreen Biosciences
5.1.1 Chipscreen Biosciences Profile
5.1.2 Chipscreen Biosciences Main Business
5.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Chipscreen Biosciences Recent Developments
5.2 Affimed NV
5.2.1 Affimed NV Profile
5.2.2 Affimed NV Main Business
5.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Affimed NV Recent Developments
5.3 Altor BioScience
5.3.1 Altor BioScience Profile
5.3.2 Altor BioScience Main Business
5.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Innate Pharma Recent Developments
5.4 Innate Pharma
5.4.1 Innate Pharma Profile
5.4.2 Innate Pharma Main Business
5.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Innate Pharma Recent Developments
5.5 Takeda
5.5.1 Takeda Profile
5.5.2 Takeda Main Business
5.5.3 Takeda Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Takeda Recent Developments
5.6 Sorrento Therapeutics
5.6.1 Sorrento Therapeutics Profile
5.6.2 Sorrento Therapeutics Main Business
5.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Sorrento Therapeutics Recent Developments
5.7 NantKwest
5.7.1 NantKwest Profile
5.7.2 NantKwest Main Business
5.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.7.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 NantKwest Recent Developments
5.8 Bristol-Myers Squibb
5.8.1 Bristol-Myers Squibb Profile
5.8.2 Bristol-Myers Squibb Main Business
5.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Bristol-Myers Squibb Recent Developments
5.9 NKT
5.9.1 NKT Profile
5.9.2 NKT Main Business
5.9.3 NKT Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 NKT Recent Developments
5.10 Henry Ford Health Services
5.10.1 Henry Ford Health Services Profile
5.10.2 Henry Ford Health Services Main Business
5.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Products, Services and Solutions
5.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Henry Ford Health Services Recent Developments
6 North America
6.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Natural Killer (NK) Cell Therapeutics Market Dynamics
11.1 Natural Killer (NK) Cell Therapeutics Industry Trends
11.2 Natural Killer (NK) Cell Therapeutics Market Drivers
11.3 Natural Killer (NK) Cell Therapeutics Market Challenges
11.4 Natural Killer (NK) Cell Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
